ATLANTA (August 19) -- Kilpatrick Townsend & Stockton announced today that attorney Alyson Wooten will serve as a featured speaker at a live webcast presented by The Knowledge Group. The webcast, which will be held Tuesday, August 25, is titled, “Abbreviated New Drug Application (ANDA) and Paragraph IV Certification: Critical Insights in 2015.”

Dr. Wooten will discuss, “The Use of Inter Partes Review Petitions in Generic Drug Litigation.” Her session will focus on the review of the competing statutes: Hatch-Waxman vs. AIA, strategies for use of IPR in the pharmaceutical context, and special issues with concurrent ANDA litigation.

For more information on the webcast, please click here.

Dr. Wooten, PharmD, focuses her practice on patent litigation across technologies including telecommunication systems, software systems, pharmaceutical and chemical products, medical devices and financial related technologies. She also has significant experience in strategic IP counseling and licensing. Registered as a patent attorney and pharmacist, Dr. Wooten has broad experience in the pharmaceutical industry, including medical services, regulatory, marketing and clinical trial analysis.

For more information about Kilpatrick Townsend, please visit:

Follow the firm on Twitter: @KTS_Law.



Knowledge Center

Match our knowledge to your needs



Scored 100 percent on the Human Rights Campaign Foundation’s 2017 Corporate Equality Index as a “Best Place to Work” for LGBT equality.